AbstractObjectivesTo investigate the prevalence of pain, clinical characteristics of pain, association between clinical features and pain of patients with Parkinson’s Disease(PD).
MethodsWe undertook a retrospective review of the medical records of patients diagnosed with PD between 2012 and 2019 at Kyung Hee University Korean Medicine Hospital at Gangdong in South Korea.
ResultsA total of 172 PD patients met entry criteria and 147 out of 172 patients(85.5%) reported pain. In comparison with general population, PD patients has high prevalence of pain. Female PD patients more frequently reported pain than male (P=0.03). 102 out of 147patients(69.3) complained of musculoskeletal pain, and musculoskeletal pain show significant difference depending on the PD motor subtypes (P=0.039). Pain was mainly locatedin the leg (57.8%) in all PD motor subtypes. Tremor-dominant PD more frequently felt pain in upper limb than postural instability-gait difficulty dominant(PIGD) PD, but it was not statistically significant.
참고문헌1. Association of Korean Medicine Professors for Cardiovascular and Neurologic Medicine. Cardiovascular and Neurological Medicine in Korean Medicine 3. Seoul: WOORI Medical Books;2016. p. 113–114.
2. Gelb DJ, Oliver E, Gilman S. Diagnostic Criteria for Parkinson Disease. JAMA Neurol. 1999; 56:1. 33–39.
![]() 3. Buhmann C, Wrobel N, Grashorn W, et al. Pain in Parkinson disease: a cross-sectional survey of its prevalence, specifics, and therapy. J Neurol. 2017; 264:4. 758–769.
![]() ![]() 4. Broen MPG, Braaksma MM, Patijn J, Weber WEJ. Prevalence of pain in Parkinson’s disease: a systematic review using the modified QUADAS tool. Mov Disord. 2012; 27:4. 480–484.
![]() ![]() 5. Zhang LM, Chen YQ, Li WJ, Sun W, Huang Y, Zou HQ. Association between mutations of SCN9A gene and pain related to Parkinsonism. Chinese J Med Genet. 2013; 30:1. 17–20.
6. Greenbaum L, Tegeder I, Barhum Y, Melamed E, Roditi Y, Djaldetti R. Contribution of genetic variants to pain susceptibility in Parkinson disease. Eur J Pain. 2012; 16:9. 1243–1250.
![]() ![]() 7. Rukavina K, Leta V, Sportelli C, et al. Pain in Parkinson’s disease: New concepts in pathogenesis and treatment. Curr Opin Neurol. 2019; 32:4. 579–588.
![]() ![]() 8. Trenkwalder C, Chaudhuri KR, Martinez MP, et al. Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson’s disease (PANDA): A double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2015; 14:12. 1161–1170.
![]() ![]() 9. Valkovic P, Minar M, Singliarova H, et al. Pain in Parkinson’s disease: A cross-sectional study of its prevalence, types, and relationship to depression and quality of life. PLoS One. 2015; 10:8.
![]() 10. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson’s disease: A base-line analysis of the DAT ATOP cohort. Neurology. 1990; 40:10. 1529–1529.
![]() 11. Pont-Sunyer C, Hotter A, Gaig C, et al. The onset of nonmotor symptoms in parkinson’s disease (the onset pd study). Mov Disord. 2015; 30:2. 229–237.
![]() ![]() 12. Chaudhuri KR, Rizos A, Trenkwalder C, et al. King’s Parkinson’s disease pain scale, the first scale for pain in PD: An international validation. Mov Disord. 2015; 30:12. 1623–1631.
![]() ![]() 13. Ministry of Employment and Labor. 2012 Korean Longitudinal Study of Ageing(KLoSA). Korea Employment Information Service;2013.
14. Duvoisin RC, Marsden CD. Note on the scoliosis of Parkinsonism. J Neurol Neurosurg Psychiatry. 1975; 38:8. 787–793.
![]() ![]() ![]() 15. Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology. 2004; 62:12. 2171–2175.
![]() ![]() 16. Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, et al. Levodopa raises objective pain threshold in Parkinson’s disease: A RIII reflex study. J Neurol Neurosurg Psychiatry. 2007; 78:10. 1140–1142.
![]() ![]() ![]() 17. Gandolfi M, Geroin C, Antonini A, Smania N, Tinazzi M. Understanding and Treating Pain Syndromes in Parkinson’s Disease. International Review of Neurobiology. 134:Academic Press Inc;2017. p. 827–858.
![]() ![]() 18. Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED. Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain. 2012; 153:4. 744–754.
![]() ![]() 19. Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M. Pain is common in Parkinson’s disease. Clin Neurol Neurosurg. 2011; 113:1. 11–13.
![]() ![]() 20. Tinazzi M, Del Vesco C, Fincati E, et al. Pain and motor complications in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2006; 77:7. 822–825.
![]() ![]() ![]() 21. Müller T, Muhlack S, Woitalla D. Pain perception, pain drug therapy and health status in patients with Parkinson’s disease. Neuroepidemiology. 2011; 37:3–4. 183–187.
![]() ![]() 22. Scott B, Borgman A, Engler H, Johnels B, Aquilonius SM. Gender differences in Parkinson’s disease symptom profile. Acta Neurol Scand. 2000; 102:1. 37–43.
![]() ![]() 23. Han CS, Pae CU. Pain and Depression: A Neurobiological Perspective of Their Relationship. Psychiatry Investig. 2015; 12:1. 1–8.
![]() ![]() ![]() 24. Beiske AG, Loge JH, Rønningen A, Svensson E. Pain in Parkinson’s disease: Prevalence and characteristics. Pain. 2009; 141:1–2. 173–177.
![]() ![]() 25. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson’s disease: A base-line analysis of the DAT ATOP cohort. Neurology. 1990; 40:10. 1529–1529.
![]() ![]() 26. Jankovic J, Kapadia AS. Functional decline in Parkinson disease. Arch Neurol. 2001; 58:10. 1611–1615.
![]() ![]() 27. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson’s disease rating scale: comparison with the unified Parkinson’s disease rating scale. Mov Disord. 2013; 28:5. 668–670.
![]() ![]() 28. Eisinger RS, Hess CW, Martinez-Ramirez D, et al. Motor subtype changes in early Parkinson’s disease. Park Relat Disord. 2017; 43:67–72.
![]() |
|